Skip to main content
. 2019 Apr 1;58(9):1649–1654. doi: 10.1093/rheumatology/kez095

Table 1.

Baseline characteristics of the patients suspected of axSpA in the ASAS, DESIR and SPACE cohort

Characteristic ASAS (n = 594) DESIR (n = 647) SPACE (n = 577)
Age at baseline, mean (s.d.), years 33.7 (11.7) 33.6 (8.6) 30.8 (8.1)
Male, n (%) 276 (46) 305 (47) 221 (38)
Caucasian, n (%) 348 (59) 577 (89) 454/484 (94)
Duration of back pain, mean (s.d.), months 85.7 (108.4)a 18.2 (10.6)a 13.3 (7.1)
IBP, n (%) 301/532 (57) 647 (100)b 396/576 (69)
Good response to NSAIDsc, n (%) 274 (46) 515/644 (80) 263/563 (47)
Peripheral arthritis, n (%) 197 (33) 363 (56) 97/575 (17)
Enthesitis, n (%) 241 (41) 312 (48) 121 (21)
Dactylitis, n (%) 23 (4) 83 (13) 35 (6)
AAU, n (%) 53 (9) 51 (8) 47 (8)
Psoriasis, n (%) 22 (4) 97 (15) 77 (13)
IBD, n (%) 8 (1) 23 (4) 38 (7)
Positive family history according to ASAS definition, n (%) 135 (23) 249 (39) 218 (38)
A positive family history of
    AS, n (%) 87 (15) 127 (20) 104 (18)
    AAU, n (%) 7 (1) 29 (4) 34 (6)
    ReA, n (%) 8 (1) 6 (1) 19/563 (3)
    IBD, n (%) 12 (2) 32 (5) 32/570 (6)
    Psoriasis, n (%) 36 (6) 129 (20) 95/571 (17)
HLA-B27 positivity, n (%) 310 (52) 376/646 (58) 246 (43)
Elevated CRP/ESR, n (%) 185 (31) 254 (39) 188 (33)
Radiographic sacroiliitisd, n (%) 119/593 (20) 172 (27) 80/570 (14)
Sacroiliitis on MRId, n (%) 189/424 (45) 207/636 (33) 207/565 (37)
Clinical diagnosis of axSpAe, n (%) 368 (62) 302 (47) 313 (54)
a

<5% missing values.

b

Inclusion criterion.

c

Back pain not present anymore or is much better 24–48 h after a full dose of NSAID.

d

Imaging based on local reading of the SI joints.

e

Level of confidence regarding the diagnosis is ≥6 in ASAS and SPACE, ≥8 in DESIR. AAU: acute anterior uveitis; ASAS: Assessment of SpondyloArthritis international Society; (ax)SpA: (axial) spondyloarthritis; DESIR: DEvenir des Spondyloarthropathies Indifférenciéés Récentes; IBP: inflammatory back pain; SPACE: SPondyloArthritis Caught Early.